Search the Newsreel

NeoGenomics to Pay $9.8 Million to Resolve Allegations of False Claims Act Violation

NeoGenomics has agreed to pay $9.8 million to settle allegations from the U.S. Justice Department that it violated the False Claims Act. The allegations center on the company providing laboratory consulting services below fair market value and paying referral-based compensation to independent consultants, which …

EOG Resources (EOG) Bernstein 42nd Annual Strategic Decisions Conference Summary

EOG Resources (EOG) presented a summary of its financial and strategic outlook at the Bernstein 42nd Annual Strategic Decisions Conference. The company highlighted its disciplined capital allocation, focus on shareholder returns, and strategic M&A activities, particularly in a volatile geopolitical and energy market environment. …

EOG Resources (EOG) Q4 2024 earnings summary

EOG Resources reported strong Q4 2024 results with $6.6 billion adjusted net income and 25% ROCE, exceeding production targets while maintaining capital discipline. The company returned $5.3 billion to shareholders through dividends and share repurchases, and increased its regular dividend by 7%. EOG also …

Neogen (NEOG) to Release Q4 2026 Financial Results on July 30

Neogen Corporation (NEOG) is set to release its Q4 and full fiscal year 2026 financial results on July 30, with analysts projecting revenues between $150M-$155M for Q4 and around $590M for the full year. GuruFocus assesses NEOG as 16.8% undervalued with a GF Value …

Neogen executives will discuss fiscal 2026 results July 30

Neogen Corporation (NASDAQ: NEOG) announced that it will release its fourth-quarter fiscal year 2026 earnings before the market opens on Thursday, July 30, 2026. Company executives will host a webcast and conference call at 8:00 a.m. Eastern time on the same day to provide …

Meeder Asset Management Inc. Increases Stock Position in EOG Resources, Inc. $EOG

Meeder Asset Management Inc. significantly increased its stake in EOG Resources, Inc. by 447.8% in the first quarter, holding 4

Mediolanum International Funds Ltd Has $10.84 Million Stock Position in EOG Resources, Inc. $EOG

Mediolanum International Funds Ltd reduced its stake in EOG Resources, Inc. by 25.7% in the first quarter, now holding 72,328 shares valued at $10.84 million. Despite this, institutional investors and hedge funds own 89.91% of the company's stock. EOG Resources reported strong Q1 earnings, …

Swiss National Bank Has $230.21 Million Stake in EOG Resources, Inc. $EOG

The Swiss National Bank increased its stake in EOG Resources, Inc. by 6.4% in the first quarter, now holding 1,592,400 shares valued at $230.21 million. Other institutional investors also adjusted their positions in the energy exploration company. EOG Resources announced a quarterly dividend of …

(NEO) Volatility Zones as Tactical Triggers

This article analyzes Neogenomics Inc. (NYSE: NEO) using AI models, highlighting strong sentiment across all horizons supporting an overweight bias. It outlines three distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also provides multi-timeframe …

Neogen Chemicals Schedules Q1 Earnings Call On July 27 At 4 PM

Neogen Chemicals to Discuss Q1FY27 Results on July 27 at 4 PM IST

498,424 Shares in Neogen Corporation $NEOG Purchased by Roubaix Capital LLC

Roubaix Capital LLC has acquired a new position in Neogen Corporation (NASDAQ: NEOG) during the first quarter, purchasing 498,424 shares valued at approximately $4.63 million. This stake represents about 0.23% of Neogen's shares and 2.2% of Roubaix's portfolio, contributing to the high institutional ownership …

Assetmark Inc. Sells 22,363 Shares of EOG Resources, Inc. $EOG

Assetmark Inc. significantly reduced its stake in EOG Resources, selling 22,363 shares and retaining 129,836 shares valued at $18.77 million. This comes as EOG Resources reported strong first-quarter earnings, exceeding analyst expectations for both EPS and revenue, alongside a 22.1% year-over-year revenue growth. Analysts …

Aware Super Pty Ltd as trustee of Aware Super Acquires Shares of 99,004 EOG Resources, Inc. $EOG

Aware Super Pty Ltd, acting as trustee for Aware Super, recently acquired 99,004 shares of EOG Resources, Inc. (NYSE:EOG) for approximately $14.31 million during the first quarter. This institutional investment is part of broader activity by various hedge funds and institutional investors who have …

NeoGenomics (NEO) Stock Looks Above Fair Value After A 134% Run

NeoGenomics (NEO) stock has seen a significant 134.1% return over the past year, but current evaluations suggest it may be overvalued. The company's P/S ratio of 2.6x is significantly higher than the Healthcare industry average of 1.5x, implying the market is pricing in a …

EOG Resources Inc. stock underperforms Friday when compared to competitors despite daily gains

EOG Resources Inc. (EOG) stock rose 1.78% to $139.89 on Friday, marking its second consecutive day of gains. Despite this increase, the stock underperformed compared to the broader market, as the S&P 500 Index fell 1.01% and the Dow Jones Industrial Average dropped 0.77% …

Zoetis' Acquisition of Neogen Genomics Business Faces Regulatory Scrutiny in Australia

The Australian regulatory body, ACCC, is scrutinizing Zoetis' proposed $160 million acquisition of Neogen Genomics business due to significant competition concerns. Both companies are major genomic testing providers for livestock, and the ACCC worries about consolidation and the acquiring firm gaining exclusive access to …

NeoGenomics (NEO) Launches PTEN IHC CDx, Does The Valuation Still Look Full?

NeoGenomics (NEO) has launched a new PTEN IHC CDx diagnostic following FDA approval, contributing to significant recent stock price appreciation. While the company is considered 3.7% undervalued by some metrics, with a fair value estimate of $15.06, its current price-to-sales ratio of 2.5x is …

EOG Resources, Inc. $EOG Shares Sold by Graphene Investments SAS

Graphene Investments SAS reduced its stake in EOG Resources by 32.9% in Q1 2026, selling 10,000 shares and leaving it with 20,400 shares valued at approximately $2.95 million. EOG Resources reported strong first-quarter earnings, beating EPS and revenue estimates, and announced a quarterly dividend …

Financiere des Professionnels Fonds d investissement inc. Purchases 35,800 Shares of EOG Resources, Inc. $EOG

Financiere des Professionnels Fonds d investissement inc. significantly increased its stake in EOG Resources, Inc. (NYSE:EOG) by purchasing an additional 35,800 shares, bringing their total holdings to 36,700 shares valued at $5.31 million. Other institutional investors also bought or sold shares of EOG Resources, …

Allspring Global Investments Holdings LLC Has $370.59 Million Position in EOG Resources, Inc. $EOG

Allspring Global Investments Holdings LLC significantly increased its stake in EOG Resources, Inc. by 5.1% in the first quarter, now holding 2,639,175 shares valued at over $370 million. Other institutional investors also adjusted their positions in the energy exploration company. Wall Street analysts maintain …

EOG Resources, Inc. $EOG Shares Purchased by Bank of New York Mellon Corp

Bank of New York Mellon Corp increased its stake in EOG Resources, Inc. (NYSE:EOG) by 5.5% in the first quarter, owning over 4.9 million shares valued at $712.5 million. Other hedge funds also adjusted their holdings, with institutional investors and hedge funds now owning …

NGMS stock holds its ground after Neogenomics revenue trends improve

Neogenomics, Inc. (NGMS) reported improved financial results, with 2024 revenue reaching $169.0 million, a 12.5% increase from the previous year, and a significant improvement in adjusted EBITDA from a $25.8 million loss in 2023 to a $3.9 million loss in 2024. This performance, driven …

PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?

This article analyzes Precipio, Inc. (PRPO) and NeoGenomics, Inc. (NEO), two oncology diagnostics companies, to determine which offers a better investment opportunity. While both operate in the cancer diagnostics market, NeoGenomics is presented as the stronger buy due to its broader scale, diversified growth …

Regency Capital Management Inc. DE Purchases Shares of 22,682 EOG Resources, Inc. $EOG

Regency Capital Management Inc. DE initiated a new position in EOG Resources, Inc. by purchasing 22,682 shares valued at approximately $3.28 million during the first quarter, representing 1.5% of its investment portfolio. Other institutional investors also adjusted their holdings, contributing to total institutional ownership …

Illinois Municipal Retirement Fund Sells 36,740 Shares of EOG Resources, Inc. $EOG

Illinois Municipal Retirement Fund reduced its stake in EOG Resources (NYSE:EOG) by 17.7% in the first quarter, selling 36,740 shares and retaining 170,769 shares valued at $24.69 million. Other institutional investors also adjusted their positions in the company. Analysts have issued varied price targets …

Diversify Wealth Management LLC Takes $1.29 Million Position in EOG Resources, Inc. $EOG

Diversify Wealth Management LLC has acquired a new position in EOG Resources, Inc., purchasing 9,311 shares valued at approximately $1.29 million. This move comes as EOG Resources reported strong first-quarter earnings, surpassing analyst expectations with an EPS of $3.41 and revenue of $6.92 billion. …

The Technical Signals Behind (EOG) That Institutions Follow

This article provides an in-depth technical analysis for Eog Resources Inc. (NYSE: EOG) based on AI models, suggesting a near-term strong sentiment transitioning to long-term positive bias. It highlights specific entry and target zones for various trading strategies—position, momentum breakout, and risk hedging—along with …

A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack

Neogen Chemicals Q4FY26 revenue rises 22% to INR 247 crore

Neogen Chemicals' (NSE:NEOGEN) Problems Go Beyond Weak Profit

Neogen Chemicals, Balaji Amines shares soar up to 11%; here's why

Neogen Chemicals Q4 FY26: PAT Surges 182%, Battery Chemicals Expansion Underway

NEOGEN: Revenue and profit rose, margins remained strong, and insurance claims are progressing

NeoGenomics (NEO) Releases Q1 2026 Earnings: Revenue Up 11.1% but EPS Misses

NeoGenomics’s (NASDAQ:NEO) Q1 CY2026: Beats On Revenue